Blocking Chemokine Receptors
Open Access
- 20 October 1997
- journal article
- review article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 186 (8) , 1189-1191
- https://doi.org/10.1084/jem.186.8.1189
Abstract
In our first review on chemokines (([1][1])), we suggested that blockade of the IL-8 receptor or inhibition of IL-8 gene expression could be a new principle for designing antiinflammatory agents. The unexpected growth of the chemokine family and consequent redundancy of the system eventually made itKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Chemokine Antagonists That Discriminate between Interleukin-8 ReceptorsJournal of Biological Chemistry, 1997
- HIV blocked by chemokine antagonistNature, 1996
- Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1Nature, 1996
- RANTES and MCP-3 Antagonists Bind Multiple Chemokine ReceptorsPublished by Elsevier ,1996
- Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent AntagonistJournal of Biological Chemistry, 1996
- Expression of a Human Mutant Monocyte Chemotactic Protein 3 inPichia pastorisand Characterization as an MCP-3 Receptor AntagonistJournal of Interferon & Cytokine Research, 1995
- Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues.The Journal of Experimental Medicine, 1995
- 1H NMR Studies of Interleukin 8 Analogs: Characterization of the Domains Essential for FunctionBiochemistry, 1994
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989